GlassScript

Medtronic, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$594Mgeneral payments (2019-2025)
$12Mresearch payments (2019-2025)
193,276clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $655K
2020 $592K
2021 $136M
2022 $121M
2023 $114M
2024 $114M
2025 $108M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurological Surgery $168M
Orthopaedic Surgery $74M
Clinical Cardiac Electrophysiology $42M
Orthopaedic Surgery of The Spine $38M
Surgery $33M
Interventional Cardiology $28M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Kevin Foley Memphis, TN Neurological Surgery $92,526,690.50
Richard Hynes Melbourne, FL Orthopaedic Surgery $28,986,591.41
Lawrence Lenke New York, NY Orthopaedic Surgery $19,199,964.57
Peter Ullrich Appleton, WI Surgery $17,960,534.39
Vivek Reddy New York, NY Clinical Cardiac Electrophysiology $10,301,975.44
Eric Peterson Miami, FL Neurological Surgery $6,544,926.69
Brian Snelling Boca Raton, FL Neurological Surgery $6,528,426.93
Tung Ngo Newport Beach, CA Internal Medicine $4,866,712.98
Regis Haid Atlanta, GA Neurological Surgery $4,732,151.39
Michael Tal New Haven, CT Vascular & Interventional Radiology $4,032,943.03

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.